Intravenous iron in digestive diseases: INTRAVENOUS IRON IN DIGESTIVE DISEASES

F. Gomollón, J. Gisbert
{"title":"Intravenous iron in digestive diseases: INTRAVENOUS IRON IN DIGESTIVE DISEASES","authors":"F. Gomollón, J. Gisbert","doi":"10.1111/J.1778-428X.2012.01170.X","DOIUrl":null,"url":null,"abstract":"SUMMARY \n \nFrom a global perspective, poor nutrition is the most important cause of iron deficiency and iron deficiency anemia. However, in developed countries gastrointestinal diseases are the most probable causes that should be taken into account in the differential diagnosis. Blood losses through mucosal ulceration, malabsorption, chronic inflammation, neoplasia, difficulties in intake of food, or a combination of these mechanisms can be found in various gastrointestinal diseases. Several iron compounds suitable for oral use are available, the most simple and most commonly used being iron salts such as iron sulfate or iron fumarate. However, oral iron is not always the best option. Intravenous (IV) iron has been shown to be effective in several observational and controlled studies. In cancer patients, oral iron has been shown to be effective in some studies, but IV iron has several advantages in this particular scenario: it is well tolerated, even in frail patients, and is quick to obtain a response, something rather convenient if prompt surgery is needed. IV iron is also widely used in chronic gastrointestinal blood loss caused by vascular malformations, a rather common scenario in patients on anticoagulant treatment. It is also relatively common in clinical gastroenterological practice to find anemia and iron deficiency in patients treated with nonsteroidal anti-inflammatory agents and/or antiplatelet drugs. IV iron is a useful and effective tool to treat iron deficiency in digestive diseases. Although we need more and larger trials to further define indications, protocols and follow-up rules in different pathologies, the available guidelines for the management of iron deficiency and anemia inflammatory bowel disease patients are good practical guides.","PeriodicalId":90375,"journal":{"name":"Transfusion alternatives in transfusion medicine : TATM","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/J.1778-428X.2012.01170.X","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion alternatives in transfusion medicine : TATM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1778-428X.2012.01170.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

SUMMARY From a global perspective, poor nutrition is the most important cause of iron deficiency and iron deficiency anemia. However, in developed countries gastrointestinal diseases are the most probable causes that should be taken into account in the differential diagnosis. Blood losses through mucosal ulceration, malabsorption, chronic inflammation, neoplasia, difficulties in intake of food, or a combination of these mechanisms can be found in various gastrointestinal diseases. Several iron compounds suitable for oral use are available, the most simple and most commonly used being iron salts such as iron sulfate or iron fumarate. However, oral iron is not always the best option. Intravenous (IV) iron has been shown to be effective in several observational and controlled studies. In cancer patients, oral iron has been shown to be effective in some studies, but IV iron has several advantages in this particular scenario: it is well tolerated, even in frail patients, and is quick to obtain a response, something rather convenient if prompt surgery is needed. IV iron is also widely used in chronic gastrointestinal blood loss caused by vascular malformations, a rather common scenario in patients on anticoagulant treatment. It is also relatively common in clinical gastroenterological practice to find anemia and iron deficiency in patients treated with nonsteroidal anti-inflammatory agents and/or antiplatelet drugs. IV iron is a useful and effective tool to treat iron deficiency in digestive diseases. Although we need more and larger trials to further define indications, protocols and follow-up rules in different pathologies, the available guidelines for the management of iron deficiency and anemia inflammatory bowel disease patients are good practical guides.
消化道疾病中的静脉注射铁:消化道疾病中的静脉注射铁
从全球范围来看,营养不良是导致缺铁和缺铁性贫血的最重要原因。然而,在发达国家,胃肠道疾病是最可能的病因,在鉴别诊断中应予以考虑。由于粘膜溃疡、吸收不良、慢性炎症、肿瘤、食物摄入困难或这些机制的组合而导致的失血可以在各种胃肠道疾病中发现。有几种适合口服的铁化合物,最简单和最常用的是铁盐,如硫酸铁或富马酸铁。然而,口服铁并不总是最好的选择。在一些观察性和对照研究中,静脉注射铁已被证明是有效的。对于癌症患者,口服铁在一些研究中已被证明是有效的,但在这种特殊情况下,静脉注射铁有几个优点:即使在虚弱的患者中,它也具有良好的耐受性,并且快速获得反应,如果需要及时手术,这是相当方便的。静脉铁也广泛用于血管畸形引起的慢性胃肠道失血,这是抗凝治疗患者中相当常见的情况。在临床胃肠病学实践中,在接受非甾体抗炎药和/或抗血小板药物治疗的患者中发现贫血和缺铁也相对常见。静脉注射铁是治疗消化系统疾病缺铁的有效工具。虽然我们需要更多和更大规模的试验来进一步确定不同病理的适应症、方案和随访规则,但现有的治疗缺铁和贫血性炎症性肠病患者的指南是很好的实用指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信